• Profile
Close

Retrospective analysis of cisplatin nephrotoxicity in patients with head and neck cancer receiving outpatient treatment with concurrent high-dose cisplatin and radiotherapy

American Journal of Clinical Oncology Apr 28, 2018

Faig J, et al. - Experts proposed an outpatient high-dose cisplatin protocol aimed at preventing nephrotoxicity and evaluated the results of its utilization in patients with squamous cell carcinoma of the head and neck (SCCHN) treated with concurrent radiotherapy. During treatment, the incidence of acute kidney injury (AKI) was 34.2%. Lower baseline weight and creatinine, higher baseline creatinine clearance, smoking, female sex, African American race, hypertension, and increased hydration and magnesium replacement requirements were the predictors associated with AKI and chronic kidney disease. Data suggested that early and late nephrotoxicity was encountered by the experts. Essentially, nephrotoxicity was not the main dose-limiting toxicity. Importance of close monitoring and additional replacement of water and electrolytes as needed, was emphasized in the findings.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay